Thor Halfdanarson/mayoclinic.org
May 2, 2025, 08:58
Thor Halfdanarson: Routine Surveillance for Cancer Metastases — Does It Help or Harm Patients?
Thor Halfdanarson, Medical Oncologist at Mayo Clinic, shared a post on X:
“This is a good piece…
“But whether detection of molecular recurrences helps patients live longer or live better is a question that has yet to be answered — and one that can be addressed only with an RCT.””
Ttile: Routine Surveillance for Cancer Metastases — Does It Help or Harm Patients?
Authors: H. Gilbert Welch and Lesly A. Dossett
You Can Read The Full Article in The New England Journal of Medicine.
More posts featuring Thor Halfdanarson at OncoDaily.com.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 19, 2025, 09:37
Jun 19, 2025, 09:29
Jun 19, 2025, 09:23
Jun 19, 2025, 09:07
Jun 19, 2025, 08:57